# Gland Pharma Limited – FDA Inspection, Apr 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/bcfef7a6-3c1d-45b7-aa02-c938c6c50db1
Source feed: FDA_Inspections

> FDA inspection 1052383 of Gland Pharma Limited, April 20, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052383
- Company Name: Gland Pharma Limited
- Inspection Date: 2018-04-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1261860 - 2025-02-25](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/2972bd2d-c5e8-4a15-963c-a84d5805c9d3)
- FDA Inspection 1245692 - 2024-05-24
- [FDA Inspection 1199204 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/3204a6bf-ba56-427c-bce5-3387799260ad)
- FDA Inspection 951916 - 2015-10-29

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.keypedia.com/companies/gland-pharma-limited/2bdef9e1-be40-4167-95c8-f08cba22365c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
